Table 1 |
|||
|
Comparison of treatment |
|||
|
Agent |
Dose |
Duration of Treatment |
Decrease in %tGHb or %HbA1c |
|
|
|||
|
Rosiglitizone |
4 mg bid |
16 weeks |
0.7% |
|
Metformin |
2500 mg |
29 weeks |
1.4% |
|
30% Protein Diet |
5 weeks |
0.8% (1.6%) |
|
|
|
|||
|
PDR 2003 [12] |
|||
|
Nuttall and Gannon Nutrition & Metabolism 2004 1:6 doi:10.1186/1743-7075-1-6 |
|||